Abacus Planning Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$442K Buy
+1,144
New +$424K 0.05% 154
2026
Q1
Sell
-671
Closed -$235K 273
2025
Q4
$235K Buy
671
+43
+7% +$14.5K 0.03% 228
2025
Q3
$203K Sell
628
-351
-36% -$109K 0.03% 241
2025
Q2
$381K Buy
979
+125
+15% +$50.3K 0.06% 158
2025
Q1
$371K Buy
854
+303
+55% +$122K 0.07% 147
2024
Q4
$203K Sell
551
-291
-35% -$122K 0.04% 208
2024
Q3
$438K Buy
842
+48
+6% +$25.6K 0.08% 123
2024
Q2
$430K Sell
794
-9
-1% -$4.76K 0.08% 118
2024
Q1
$416K Buy
803
+23
+3% +$11.4K 0.08% 121
2023
Q4
$368K Sell
780
-129
-14% -$59.6K 0.08% 127
2023
Q3
$396K Buy
909
+146
+19% +$66.2K 0.1% 114
2023
Q2
$339K Buy
763
+290
+61% +$134K 0.08% 127
2023
Q1
$217K Hold
473
0.06% 168
2022
Q4
$243K Hold
473
0.07% 151
2022
Q3
$215K Hold
473
0.06% 156
2022
Q2
$228K Hold
473
0.07% 164
2022
Q1
$232K Hold
473
0.06% 181
2021
Q4
$219K Buy
+473
New +$199K 0.06% 185

Other funds holding ELV

Abacus Planning Group's ELV Position: Q2 2026 in Review

Abacus Planning Group opened a new position in Elevance Health (ELV) in Q2 2026: 1,144 shares worth $442K. The stake represents 0.05% of the portfolio and ranks #154 among its holdings. This is a return to the name: Abacus Planning Group previously reported a position in ELV as recently as Q4 2025.

Abacus Planning Group first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Abacus Planning Group held 1,144 shares of Elevance Health worth $442K as of Q2 2026.
  • Elevance Health was a new Abacus Planning Group position in Q2 2026.
  • Elevance Health made up 0.05% of Abacus Planning Group's portfolio in Q2 2026, its #154 holding.
  • Abacus Planning Group first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.